NICE issues Final Draft Guidance recommending DARZALEX® (daratumumab) plus bortezomib, lenalidomide and dexamethasone for untreated multiple myeloma when a stem cell transplant is suitable
Johnson & Johnson has announced that the National Institute for Health and Care Excellence (NICE) has published Final Draft Guidance recommending DARZALEX® (daratumumab) plus bortezomib, lenalidomide and dexamethasone (D-VRd) followed […]
IUCS 2026 provides free urological cancer education to more than 1,300 healthcare professionals
More than 1,300 healthcare professionals from 113 countries learned about the latest advances in urological cancer treatments at the 2026 International Urology Cancer Summit. The free international educational event was […]
HCA Healthcare UK invests £15million to introduce advanced MR-guided radiotherapy with Elekta Unity MR‑Linac at The Harley Street Clinic
HCA Healthcare UK (HCA UK) has expanded its radiotherapy capabilities with the introduction of the Elekta Unity MR‑Linac at The Harley Street Clinic, bringing highly personalised radiotherapy treatment to patients […]
AI analysis of routine MRI scans links muscle and body fat to outcomes for multiple myeloma patients
Researchers at The Royal Marsden NHS Foundation Trust have shown that routine whole-body MRI scans could reveal far more about a patient’s health than previously thought. Using a new artificial […]
Jazz Pharmaceuticals makes Enrylaze® (recombinant Erwinia asparaginase) commercially available in the UK
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) has announced the commercial availability of Enrylaze® (a recombinant Erwinia asparaginase) in the UK. The medicine is indicated for use as a component of a […]
BigHat Biosciences announces first patient dosed in Phase 1 Trial evaluating BHB810, a Novel CDH17-Directed Antibody-Drug Conjugate, for the treatment of gastric cancer and other advanced gastrointestinal tumours
SAN MATEO, Calif.–(BUSINESS WIRE)–BigHat Biosciences, a clinical-stage, AI-driven protein therapeutics platform company, has announced that the first patient has been dosed in its Phase 1 clinical trial evaluating BHB810, a […]
Immune ‘blind spot’ in cancer focus of new study
A new project funded by Cancer Research UK will explore why half of patients with a silent blood condition called smouldering myeloma will go on to develop an incurable cancer. […]
New research uncovers how a key anti-cancer immune pathway is activated after DNA damage
Researchers have developed a powerful new tool that has revealed surprising insights into how cells activate one of the body’s most important anti-cancer immune responses following DNA damage. The team […]
NICE issues final draft guidance recommending IMBRUVICAâ (ibrutinib) with R-CHOP for untreated mantle cell lymphoma when a stem cell transplant is suitable
Johnson & Johnson is pleased that the National Institute for Health and Care Excellence (NICE) has published Final Draft Guidance recommending IMBRUVICA® (ibrutinib) in combination with rituximab, cyclophosphamide, doxorubicin, vincristine […]
New, cheaper blood test could help detect breast cancer recurrence earlier
New research funded by Breast Cancer Now* has shown that more people could benefit from a new type of blood test that can predict the return of breast cancer, months […]
